Hilar Cholangiocarcinoma Clinical Trial
— CTREGOfficial title:
Superior Bilioenteric Anastomosis by Magnetic Compressive Technique: A Multicenter, Prospective, Randomized Controlled Trial
The purpose of this study is to determine whether the magnetic compressive anastomosis has a better outcomes than traditional manual anastomosis on superior bilioenteric anastomosis.
Status | Recruiting |
Enrollment | 70 |
Est. completion date | June 2019 |
Est. primary completion date | June 2018 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years to 75 Years |
Eligibility |
Inclusion Criteria: - Patients with age between 18 to 75 - Patients' gender was not limited - Patients who were well-diagnosed and had the indication for superior bilioenteric anastomosis. - Patients whose lifetimes will be longer than 12 months. - Patients who are willing to join this clinical trial and informed consent form voluntarily. Exclusion Criteria: - Woman during pregnancy or lactation or anyone with mental disorder - The wall of hepatic duct or jejunum was too thick so that the attractive force of magnetic device cannot meet the requirements of compression. - Any anatomical variation in bile ducts system or the inner diameter is too small so that the magnetic device cannot place in. - Any foreign body has been implanted in body, such as heart pacemaker. - Surgical contraindication, including: Child-Pugh C with hepatic encephalopathy Anyone with heart, lung, kidney dysfunction or other organ dysfunction, and cannot tolerate surgery.Hepatic ducts stone disease, who was diagnosed as Acute Cholangitis of Severe Type, especially complicated with bacteremia or septic shock. End stage disease, complicated with biliary cirrhosis or portal hypertension.Patients with long-term obstructive jaundice, dehydration, electrolyte disturbance or coagulation defects; Patients have the tendency or history of bleeding. - Any other disease in perioperation periods which needs MRI examination in the next 8 weeks post operation. |
Country | Name | City | State |
---|---|---|---|
China | First Affiliated Hospital of Xian JiaotongUniversity | Xi'an | Shaanxi |
China | The First Affiliated Hospital of Xi'an Jiaotong University | Xi'an | Shaanxi |
Lead Sponsor | Collaborator |
---|---|
First Affiliated Hospital Xi'an Jiaotong University | First Affiliated Hospital of Xinjiang Medical University, First Affiliated Hospital, Sun Yat-Sen University, General Hospital of Ningxia Medical University, Shaanxi Provincial People's Hospital, Tang-Du Hospital |
China,
Avaliani M, Chigogidze N, Nechipai A, Dolgushin B. Magnetic compression biliary-enteric anastomosis for palliation of obstructive jaundice: initial clinical results. J Vasc Interv Radiol. 2009 May;20(5):614-23. doi: 10.1016/j.jvir.2009.01.019. — View Citation
Chopita N, Vaillaverde A, Cope C, Bernedo A, Martinez H, Landoni N, Jmelnitzky A, Burgos H. Endoscopic gastroenteric anastomosis using magnets. Endoscopy. 2005 Apr;37(4):313-7. — View Citation
Fan C, Ma J, Zhang HK, Gao R, Li JH, Yu L, Wu Z, Lv Y. Sutureless intestinal anastomosis with a novel device of magnetic compression anastomosis. Chin Med Sci J. 2011 Sep;26(3):182-9. — View Citation
Frattaroli FM, Reggio D, Guadalaxara A, Illomei G, Pappalardo G. Benign biliary strictures: a review of 21 years of experience. J Am Coll Surg. 1996 Nov;183(5):506-13. — View Citation
House MG, Cameron JL, Schulick RD, Campbell KA, Sauter PK, Coleman J, Lillemoe KD, Yeo CJ. Incidence and outcome of biliary strictures after pancreaticoduodenectomy. Ann Surg. 2006 May;243(5):571-6; discussion 576-8. — View Citation
Sicklick JK, Camp MS, Lillemoe KD, Melton GB, Yeo CJ, Campbell KA, Talamini MA, Pitt HA, Coleman J, Sauter PA, Cameron JL. Surgical management of bile duct injuries sustained during laparoscopic cholecystectomy: perioperative results in 200 patients. Ann — View Citation
Stepanov EA, Vasil'ev GS, Nikolaev VV. [The treatment of intestinal fistulae in children by applying a by-pass anastomosis using magnetic devices]. Khirurgiia (Mosk). 1992 Nov-Dec;(11-12):93-5. Russian. — View Citation
Yan JQ, Peng CH, Ding JZ, Yang WP, Zhou GW, Chen YJ, Tao ZY, Li HW. Surgical management in biliary restricture after Roux-en-Y hepaticojejunostomy for bile duct injury. World J Gastroenterol. 2007 Dec 28;13(48):6598-602. — View Citation
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Bilioenteric anastomotic leakage | 1 month post operation | ||
Secondary | Length of bilioenteric anastomosis time | during operation | ||
Secondary | Number of patients who have discharged the device on the date expected. | 1 to 4 weeks postoperation | ||
Secondary | Number of patients who have been diagnosed as discharge disorder of magnetic device | less than 1 week or more than 4 weeks | ||
Secondary | average length of postoperative hospital stay | 3 months | ||
Secondary | Times of pathological examination of bile duct's remnant of Klatskin' tumor | during operation | ||
Secondary | Bilioenteric anastomotic stricture | Time Frame: 1,3,6,12-month post operation |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05678218 -
Preoperative Evaluation of Lymph Nodes of Cholangiocarcinoma
|
||
Enrolling by invitation |
NCT01715402 -
Optimization of Health Expenditure in Liver Surgery
|
N/A | |
Completed |
NCT03320980 -
RALPPS in Patients With Hilar and Intrahepatic Cholangiocarcinoma
|
N/A | |
Completed |
NCT00721175 -
Efficacy and Cost Analysis of Plastic Stent Compare to Metallic Stent in Hilar Cholangiocarcinoma
|
Phase 4 | |
Recruiting |
NCT05626127 -
MRI-based Clinico-radiomics Predicting Lymph Node Metastasis Status of Hilar Cholangiocarcinoma
|
||
Terminated |
NCT02082522 -
Efficacy and Safety Study of PDT Using Photofrin in Unresectable Advanced Perihilar Cholangiocarcinoma (OPUS)
|
Phase 3 | |
Active, not recruiting |
NCT05239169 -
Immunotherapy With Durva and Treme With or Without Capecitabine in Adjuvant Treatment for Biliary Tract Cancer
|
Phase 2 | |
Recruiting |
NCT02178280 -
Safety Study of Liver Transplantation for Hilar Cholangiocarcinoma
|
Phase 1/Phase 2 | |
Terminated |
NCT02955771 -
Efficacy and Safety Study of PDT Using Deuteporfin for Unresectable Advanced Perihilar Cholangiocarcinoma
|
Phase 2 | |
Recruiting |
NCT03132649 -
Impact of Three-dimensional Visualization on Operation Strategy and Complications for Hilar Cholangiocarcinoma
|
||
Recruiting |
NCT04561453 -
Feasibility Study of Multi-Platform Profiling of Resected Biliary Tract Cancer
|
||
Recruiting |
NCT02108145 -
Percutaneous Bilateral Versus Unilateral Metal Stent for Hilar Cholangiocarcinoma
|
Phase 2/Phase 3 | |
Enrolling by invitation |
NCT03739164 -
Tampa Associating Microwave Liver Ablation With Portal Vein Ligation for Staged Hepatectomy (TAMLAPS)
|
||
Recruiting |
NCT01549795 -
Liver Transplantation for Hilar Cholangiocarcinoma in Association With Neoadjuvant Radio- and Chemo-therapy
|
N/A | |
Recruiting |
NCT06106750 -
Endoscopic Scissors Cutting Nasobiliary Duct VS Bilateral Plastic Stent
|
N/A | |
Active, not recruiting |
NCT02042443 -
Trametinib or Combination Chemotherapy in Treating Patients With Refractory or Advanced Biliary or Gallbladder Cancer or That Cannot Be Removed by Surgery
|
Phase 2 | |
Recruiting |
NCT05551299 -
Treatment of Non-resectable Bile Duct Cancer With Radiofrequency Ablation or Photodynamic Therapy
|
Phase 4 | |
Completed |
NCT01093222 -
Sorafenib Tosylate and Erlotinib Hydrochloride in Treating Patients With Locally Advanced, Unresectable, or Metastatic Gallbladder Cancer or Cholangiocarcinoma
|
Phase 2 | |
Enrolling by invitation |
NCT04779788 -
I-125 Seeds Loaded Stent Insertion for Inoperable Hilar Cholangiocarcinoma
|
N/A | |
Completed |
NCT04611100 -
Efficacy of Intraductal Radiofrequency Ablation in Combination With Metallic Biliary Stenting in Advanced Hilar Cholangiocarcinoma
|
N/A |